Malaria News and Research

Latest Malaria News and Research

Paper-strip test could identify counterfeit versions of faked medicines in the world

In a thrust against the major problem of counterfeit medicines sold in developing countries, which causes thousands of illnesses and deaths annually, scientists today described development of a simple, paper-strip test that people could use to identify counterfeit versions of one of the most-frequently faked medicines in the world.

20 Aug 2012

New birth-control strategy for mosquitoes can combat malaria

Using information about the unique mating practices of the male malaria mosquito ― which, unlike any other insect, inserts a plug to seal its sperm inside the female ― scientists are zeroing in on a birth-control drug for Anopheles mosquitoes, deadly carriers of the disease that threatens 3 billion people, has infected more than 215 million and kills 655,000 annually.

20 Aug 2012

New book on malaria tells story of Plasmodium falciparum Genome Project

Few infectious diseases can rival malaria's ability to kill and cripple. Each year the disease causes hundreds of millions of people to be sickened and more than a million - mostly African children under the age of five - die.

18 Aug 2012

Franchise clinics improve healthcare access for children in developing world

Franchise health clinics could substantially increase access to essential vaccinations and treatments among children living in low-income countries, regardless of their household income status, report researchers.

17 Aug 2012

Blog examines use of controversial HIV drug in Malawi

This post in the Center for Global Health Policy's "Science Speaks" blog examines the use of stavudine, "also known as d4T, an antiretroviral treatment that was dropped in wealthy countries years ago and that the World Health Organization has recommended stop being included in treatment programs," to treat HIV in Malawi.

17 Aug 2012

Nostrum, VCU sign license agreement to develop inhaled dapsone for respiratory diseases

Virginia Commonwealth University and Nostrum Pharmaceuticals, LLC, are pleased to announce the signing of a license agreement for the development of inhaled dapsone for the treatment of respiratory diseases.

17 Aug 2012

Rhomboid enzymes and malaria treatment: an interview with Sinisa Urban

Rhomboid enzymes live in the cell’s membrane where their job is to cut the anchors of proteins, which releases the target proteins from the membrane.

16 Aug 2012

Gates looks to develop 'next-generation toilets' for developing world

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, on Tuesday "announced the winners of the Reinvent the Toilet Challenge -- an effort to develop 'next-generation' toilets that will deliver safe and sustainable sanitation to the 2.5 billion people worldwide who don't have it," according to a foundation press release.

16 Aug 2012

Article describes novel technique to study interactions between HIV-1 and P. falciparum

The World Health Organization estimates that in 2011 there were 216 million cases of malaria and 34.2 million people living with HIV. These diseases particularly afflict sub-Saharan Africa, where large incidence of co-infection result in high mortality rates. Yet, in spite of this global pandemic, interactions between the parasite that causes malaria, Plasmodium falciparum, and HIV-1 are poorly understood.

16 Aug 2012

Researchers discover why people with sickle cell disease get milder cases of malaria

Researchers at Duke University Medical Center may finally have discovered why people with sickle cell disease get milder cases of malaria than individuals who have normal red blood cells.

16 Aug 2012

Genocea commences GEN-003 Phase 1/2a study in moderate-to-severe HSV-2 infection

Genocea Biosciences announced today that it has initiated a Phase 1/2a clinical study with its lead candidate, GEN-003. GEN-003 is an investigational vaccine designed to stimulate T cell and B cell immune responses to potentially reduce the frequency and severity of clinical outbreaks associated with moderate-to-severe Herpes Simplex Virus type 2 (HSV-2) infection.

16 Aug 2012

U.S. support of PEPFAR, Global Fund helping to achieve global AIDS, TB, malaria goals

In this post in Huffington Post's "Impact" blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis (TB) and Malaria, examines "the success of U.S. efforts to promote better global health through support for [PEPFAR] and the Global Fund to Fight AIDS, Tuberculosis and Malaria."

15 Aug 2012

Overtreatment of malaria in central, south Asia leading to neglect of other diseases, study finds

"Over diagnosis and mistreatment of malaria in central and south Asia may be widespread, leading to the neglect of other serious illnesses, according to a new study from Afghanistan," published in the British Medical Journal last month, SciDev.Net reports.

15 Aug 2012

Antisense therapy shows promise in treating toxoplasmosis

A targeted approach to treating toxoplasmosis, a parasitic disease, shows early promise in test-tube and animal studies, where it prevented the parasites from making selected proteins. When tested in newly infected mice, it reduced the number of viable parasites by more than 90 percent, researchers from the University of Chicago Medicine report in the Proceedings of the National Academy of Sciences.

14 Aug 2012

CBIS initiates CS-TATI-1 GMP development plan

Cannabis Science (CBIS), a pioneering U.S. Biotech Company developing pharmaceutical to meet global public health challenges is pleased to announce the initiation of GMP development plan for CS-TATI-1 with the initial production of CS-TATI-1 to be performed in Colorado under C-GMP conditions evaluated by the FDA for initial human studies to treat HIV associated Kaposi Sarcoma.

13 Aug 2012

NIH awards ADi Phase II SBIR grant to scan Plasmodium falciparum proteome for protective antigens

Antigen Discovery, Inc. today announced that it has received a Phase II Small Business Innovation and Research award from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The three-year award, totaling approximately $ 2.5 million, is a continuation of a Phase I SBIR grant to scan the Plasmodium falciparum proteome for protective antigens.

13 Aug 2012

IRIN examines administration of methadone as treatment for people who inject drugs in Bangladesh

"Methadone treatment is proving to be the most efficient way to wean people in Bangladesh from addiction to buprenorphine, a pharmaceutical drug, and health experts say it should be expanded to reach thousands more drug users to prevent the spread of HIV," IRIN reports.

10 Aug 2012

President's Malaria Initiative contributing to 'major progress' against disease, should be expanded

In this post in The Hill's "Congress Blog," Kent Campbell, director of the Malaria Control Program at PATH, and Jonathon Simon, chair of the Department of International Health and director of the Center for Global Health and Development at the Boston University School of Public Health, write that "major progress has been made in the fight against malaria, thanks in large part to the efforts of the President's Malaria Initiative (PMI)," and call the effort "a shining example of the profound impact the U.S. is making in global health."

9 Aug 2012

Communal violence in India forces up to 400,000 into overcrowded camps without sufficient food, water, medicine

"Hundreds of thousands of people sheltering in squalid, overcrowded camps in India's northeast desperately need food, water and medicines after fleeing some of the worst communal violence in a decade, officials and aid workers said on Monday," AlertNet reports.

8 Aug 2012

BioDiem granted European patent for antimicrobial drug

Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, fungi and protozoa. The patent provides protection around BDM-I as a treatment for vulvovaginitis, a general term for inflammation of the vulva or vagina.

7 Aug 2012

Malaria News and Research

Latest Malaria News and Research

Paper-strip test could identify counterfeit versions of faked medicines in the world

New birth-control strategy for mosquitoes can combat malaria

New book on malaria tells story of Plasmodium falciparum Genome Project

Franchise clinics improve healthcare access for children in developing world

Blog examines use of controversial HIV drug in Malawi

Nostrum, VCU sign license agreement to develop inhaled dapsone for respiratory diseases

Rhomboid enzymes and malaria treatment: an interview with Sinisa Urban

Gates looks to develop 'next-generation toilets' for developing world

Article describes novel technique to study interactions between HIV-1 and P. falciparum

Researchers discover why people with sickle cell disease get milder cases of malaria

Genocea commences GEN-003 Phase 1/2a study in moderate-to-severe HSV-2 infection

U.S. support of PEPFAR, Global Fund helping to achieve global AIDS, TB, malaria goals

Overtreatment of malaria in central, south Asia leading to neglect of other diseases, study finds

Antisense therapy shows promise in treating toxoplasmosis

CBIS initiates CS-TATI-1 GMP development plan

NIH awards ADi Phase II SBIR grant to scan Plasmodium falciparum proteome for protective antigens

IRIN examines administration of methadone as treatment for people who inject drugs in Bangladesh

President's Malaria Initiative contributing to 'major progress' against disease, should be expanded

Communal violence in India forces up to 400,000 into overcrowded camps without sufficient food, water, medicine

BioDiem granted European patent for antimicrobial drug

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Malaria News and Research

Latest Malaria News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in